Skip to Main Content

Print | Bookmark | | Font Size: + |

December 19, 2024

LCD and Policy Article Revisions Summary for December 19, 2024

Joint DME MAC Publication

Outlined below are the principal changes to the DME MAC Local Coverage Determination (LCD) and Policy Article (PA) that have been revised and posted. The policy included is Intravenous Immune Globulin. Please review the entire LCD and related PA for complete information.

Intravenous Immune Globulin

LCD

Intravenous Immune Globulin LCDExternal Website

Revision Effective Date: 01/01/2025

HCPCS CODES:

  • Added: HCPCS code J1552 to Group 1 Codes

12/19/2024: Pursuant to the 21st Century Cures Act, these revisions do not require notice and comment because the revisions are non-discretionary updates due to CMS HCPCS coding determinations.

PA

Intravenous Immune Globulin PAExternal Website

Revision Effective Date: 01/01/2025

CODING GUIDELINES:

  • Revised: Direction for billing ALYGLO using HCPCS code J1599 for dates of service on or after December 15, 2023
  • Added: Direction for billing ALYGLO using HCPCS code J1552, effective for dates of service on or after January 01, 2025

12/19/2024: At this time the 21st Century Cures Act applies to new and revised LCDs which require comment and notice. This revision is to an article that is not a local coverage determination.

Note: The information contained in this article is only a summary of revisions to the LCDs and/or PAs. For complete information on any topic, you must review the LCDs and/or PAs.

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved